The TGA have recently issued a safety advisory for listed medicines containing herbal ingredients from the Artemisia species after becoming aware of studies that indicate certain Artemisia species may pose a risk during pregnancy.

Though the TGA have stated that no adverse event reports related to the use of listed medicines containing Artemisia species during pregnancy have been received, an investigation into the level of risk associated with different Artemisia species is being conducted.

For more information about the safety advisory for Artemisia species, including next steps, likely outcomes, and sponsor obligations, please see today's technical alert.